The in vivo experiment conducted by Yao et al. showed that a RON monoclonal antibody could inhibit the activity of RONΔ160, which inhibits the growth of colon cancer cells and has a synergistic antitumor effect with cytotoxic drugs [20]. This evidence concerns the gene MST1R and malignant colon neoplasm.